RXRX · Recursion Pharmaceuticals, Inc. · Fails to Deliver
Market Cap
$1.94B
Shares
535.34M
Fails to deliver — shares from a trade that were not delivered to the buyer by the settlement date — published by the SEC twice a month. Persistent fails can reflect settlement problems or naked short selling.
Fails to Deliver History
| Settlement Date | Quantity | Price | Value |
|---|---|---|---|
| 2026-08-14 | 37,071 | $3.31 | $122,705 |
| 2026-08-12 | 4,705 | $3.35 | $15,762 |
| 2026-08-11 | 6 | $3.29 | $20 |
| 2026-08-10 | 7,517 | $3.22 | $24,205 |
| 2026-08-05 | 8,958 | $3.31 | $29,651 |
| 2026-08-04 | 54,030 | $3.18 | $171,815 |
| 2026-08-03 | 325 | $3.00 | $975 |
| 2026-07-30 | 14 | $2.97 | $42 |
| 2026-07-29 | 23 | $3.05 | $70 |
| 2026-07-23 | 104,787 | $2.98 | $312,265 |
| 2026-07-21 | 2,972,584 | $2.89 | $8,590,768 |
| 2026-07-20 | 2,474,821 | $2.95 | $7,300,722 |
| 2026-07-17 | 2,839,875 | $3.02 | $8,576,423 |
| 2026-07-16 | 252 | $3.31 | $834 |
| 2026-07-13 | 187,040 | $3.56 | $665,862 |
| 2026-07-09 | 25,900 | $3.72 | $96,348 |
| 2026-07-08 | 11,490 | $3.84 | $44,122 |
| 2026-07-07 | 7,833 | $3.96 | $31,019 |
| 2026-07-02 | 3,037,759 | $3.67 | $11,148,576 |
| 2026-07-01 | 5,875 | $3.67 | $21,561 |
| 2026-06-30 | 973,833 | $3.69 | $3,593,444 |
| 2026-06-29 | 1,393,711 | $3.52 | $4,905,863 |
| 2026-06-24 | 7,535 | $3.16 | $23,811 |
| 2026-06-23 | 41,994 | $3.18 | $133,541 |
| 2026-06-22 | 763,878 | $3.23 | $2,467,326 |
| 2026-06-17 | 45,693 | $3.18 | $145,304 |
| 2026-06-16 | 42,067 | $3.29 | $138,400 |
| 2026-06-15 | 14,099 | $3.15 | $44,412 |
| 2026-06-12 | 41,526 | $3.15 | $130,807 |
| 2026-06-10 | 16,440 | $3.22 | $52,937 |
Showing 1–30 of 30 settlements
Key facts
CIK
1601830
CUSIP
75629V104
13F (30d)
194 filings
194 filers
Visit website
Investor relations